Sivik Global Healthcare’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-50,000
| Closed | -$4.97M | – | 57 |
|
|
2019
Q3 | $4.97M | Sell |
50,000
-10,000
| -17% | -$993K | 2.51% | 23 |
|
|
2019
Q2 | $5.55M | Hold |
60,000
| – | – | 1.34% | 17 |
|
|
2019
Q1 | $5.66M | Buy |
+60,000
| New | +$5.66M | 2.09% | 20 |
|
|
2018
Q4 | – | Sell |
-50,000
| Closed | -$4.48M | – | 68 |
|
|
2018
Q3 | $4.48M | Buy |
50,000
+20,000
| +67% | +$1.79M | 1.6% | 29 |
|
|
2018
Q2 | $2.38M | Buy |
+30,000
| New | +$2.38M | 0.92% | 45 |
|
|
2018
Q1 | – | Sell |
-50,000
| Closed | -$5.22M | – | 77 |
|
|
2017
Q4 | $5.22M | Sell |
50,000
-5,000
| -9% | -$522K | 1.94% | 19 |
|
|
2017
Q3 | $8.02M | Sell |
55,000
-5,000
| -8% | -$729K | 2.73% | 7 |
|
|
2017
Q2 | $7.79M | Buy |
60,000
+12,500
| +26% | +$1.62M | 2.85% | 5 |
|
|
2017
Q1 | $5.91M | Sell |
47,500
-20,000
| -30% | -$2.49M | 2.75% | 10 |
|
|
2016
Q4 | $7.81M | Sell |
67,500
-5,000
| -7% | -$579K | 3.73% | 3 |
|
|
2016
Q3 | $7.58M | Buy |
72,500
+17,500
| +32% | +$1.83M | 3.82% | 4 |
|
|
2016
Q2 | $5.43M | Buy |
55,000
+15,000
| +38% | +$1.48M | 2.7% | 8 |
|
|
2016
Q1 | $4M | Hold |
40,000
| – | – | 1.77% | 24 |
|
|
2015
Q4 | $4.79M | Sell |
40,000
-10,000
| -20% | -$1.2M | 2.27% | 16 |
|
|
2015
Q3 | $5.41M | Buy |
50,000
+10,300
| +26% | +$1.11M | 2.62% | 11 |
|
|
2015
Q2 | $4.6M | Sell |
39,700
-10,300
| -21% | -$1.19M | 1.59% | 24 |
|
|
2015
Q1 | $5.76M | Sell |
50,000
-16,299
| -25% | -$1.88M | 1.96% | 14 |
|
|
2014
Q4 | $7.42M | Buy |
66,299
+31,299
| +89% | +$3.5M | 3% | 4 |
|
|
2014
Q3 | $3.32M | Buy |
35,000
+20,000
| +133% | +$1.9M | 1.51% | 31 |
|
|
2014
Q2 | $2.58M | Sell |
15,000
-24,160
| -62% | -$4.15M | 1.3% | 36 |
|
|
2014
Q1 | $2.73M | Sell |
39,160
-840
| -2% | -$58.6K | 1.71% | 24 |
|
|
2013
Q4 | $3.38M | Buy |
+40,000
| New | +$3.38M | 2.4% | 12 |
|